2020•Neurological SciencesRequires access

Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results

Ruggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, Claudio Gasperini, Cinzia Scandellari, Rocco Totaro, Nicola De Rossi, Silvia Masera, Valentina Zipoli, Francesco Patti, on behalf of the WANT Investigators

Open publisher page 16 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Natalizumab, Expanded Disability Status Scale, Multiple sclerosis, Medicine, Observational study, Physical therapy, Absenteeism, Relapsing remitting

Related papers

Back to paper searchBrowse research topicsOriginal source
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results — Research Paper | ScholarLens